| CAS No.: | 214047-00-4 |
|---|---|
| Formula: | C39h75n7o10 |
| Environmental Protection: | Yes |
| Certification: | Kgmp |
| Color: | White |
| Classification: | Amino Acid |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Description
MeTox is developed by May Pharma Korea Limited that approved by KDA on 2004 which had been proved a better effect .
The most common complications following injection include bruising at the injection site, mild headache, dry eye, drooping eyelids and uneven look of skin. Most of these results are temporary, undesired effects will fade and then disappear over time.
Adverse effects are higher when treating medical ailments, a combination of the higher doses administered and higher risk factors associated with the specific illness being treated. Rarely, it can cause spread beyond the site of injection. If it travels to the respiratory muscles, respiratory paralysis can occur.
Duration of effects:
The effect of MeTox treatment lasts for 4-6 months. The treatment needs to be repeated after the effect wears
Metox acts on the cholinergic motor nerve endings, in some way to antagonize the role of calcium ions,
Interfere with the release of acetylcholine from the motor nerve endings,
So that muscle fibers can not shrink so that the muscles relax to achieve the purpose of wrinkle beauty,
And the greater the toxicity, the better wrinkle cosmetic effect.
Face wrinkles are mostly caused by the muscles of the facial expression.Using Metox injection paralysis weakens the formation of wrinkled facial muscles,
Suppliers with verified business licenses
){kind=link}
){kind=link}